LOXICOM 0.5 MGML VETERINARY

Pays: Israël

Langue: anglais

Source: Ministry of Health

Achète-le

Télécharger Notice patient (PIL)
10-03-2019

Ingrédients actifs:

MELOXICAM

Disponible depuis:

COMEX LTD

forme pharmaceutique:

SUSPENSION

Composition:

MELOXICAM 0.5 MG/ML

Mode d'administration:

PER OS

Type d'ordonnance:

Required

Fabriqué par:

NORBROOK LABORATORIES LTD, IRELAND

indications thérapeutiques:

Cats: Alleviation of inflammation and pain in chronic musculo-skeletal disorders. Dogs: Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders .

Date de l'autorisation:

2019-06-30

Notice patient

                                _SUMMARY OF PRODUCT CHARACTERISTICS _
_VETERINARIAN PRESCRIPTION ONLY MEDICINE _
_FOR ANIMAL USE ONLY _
1.
NAME FORM AND STRENGTH OF THE VETERINARY MEDICIN
Loxicom 0.5 mg/ml, oral suspension
2.
ACTIVE INGREDIENTS
Each ml Contains:
Meloxicam
0.5mg
Also contains:
Sodium Benzoate 1.5 Mg
For a full list of excipients, see section 12 “further
information”
3.
INDICATIONS FOR USE
Dogs:
Alleviation of inflammation and pain in both acute and chronic
musculo-skeletal
disorders
Cats:
Alleviation of inflammation and pain in chronic musculo-skeletal
disorders
THERAPEUTIC GROUP:
NSAID’s
4.
CONTRAINDICATIONS
Do not use in pregnant or lactating animals.
Do not use in animals suffering from gastrointestinal disorders such
as irritation and haemorrhage,
impaired hepatic, cardiac or renal function and haemorrhagic
disorders.
Do not use in case of hypersensitivity to the active substance or to
any of the excipients.
Do not use in dogs and cats less than 6 weeks of age.
5.
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Typical adverse reactions of non-steroidal anti-inflammatory drugs
(NSAIDs) such as loss of
appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal
failure have occasionally
been reported.
In very rare cases, haemorrhagic diarrhoea, haematemesis,
gastrointestinal ulceration and
elevated liver enzymes have been reported.
These adverse reactions occur generally within the first treatment
week and are in
most cases transient and disappear following termination of the
treatment but in very
rare cases may be serious or fatal.
If you notice any serious effects or other effects not mentioned in
this leaflet, please
inform your veterinary surgeon.
Side effects can be reported to the Ministry of Health by clicking on
the link "Reporting
adverse events due to drug treatment" found on the home page of the
Ministry of
Health website (www.health.gov.il) which refers to the online form for
reporting
adverse events, or by entering the link:
_ _
_https://forms.gov.il/globaldata/getsequence/getsequence.aspx?formType=A
                                
                                Lire le document complet
                                
                            

Documents dans d'autres langues

Notice patient Notice patient arabe 10-03-2019
Notice patient Notice patient hébreu 10-03-2019

Rechercher des alertes liées à ce produit

Afficher l'historique des documents